A superoxide anion radical-activatable Golgi-targeting prodrug-based albumin complex for synergistic chemo-immunotherapy of triple-negative breast cancer.

Triple-negative breast cancer (TNBC) poses major treatment difficulties because of its aggressive behavior, the absence of targetable receptors, and resistance to chemotherapy, and an immunosuppressive tumor microenvironment (TME) promotes metastasis…

Preview only. Read the full abstract at the source